Fulgent Genetics Equity 2024

Fulgent Genetics Aktienanalyse

What does Fulgent Genetics do?

Fulgent Genetics Inc. is a US company founded in 2011 by Jianxing (Justin) Liu and Ming Hsieh. The company has undergone remarkable development and is now active in the field of genomics and genetics. Fulgent Genetics' business model is based on the development and distribution of solutions for the diagnosis of genetic diseases. The company offers a variety of products and services that enable doctors, clinics, and laboratories to make effective diagnoses based on genetics. One of Fulgent Genetics' main divisions is the Clinical Diagnostics department, which offers a wide range of diagnostic products that allow for both molecular diagnoses and the creation of clinical profiles for patients. This enables doctors and clinics to quickly and accurately detect and treat specific diseases. Another important division of Fulgent Genetics is the Research department, which focuses on the discovery and development of new technologies and testing procedures. These technologies and procedures are of great interest to the scientific community and are used in research or clinical studies. Fulgent Genetics also offers a Pharmacogenomics department, which is a growing segment in the personalized medicine market. The goal here is to tailor medications to the patient's genetic makeup. Fulgent Genetics' technology allows for the analysis of a patient's current genetic makeup and recommends medications based on that. Another important area of Fulgent Genetics is the direct-to-consumer sales of tests. This is particularly significant in the field of ancestry and genealogy research. Fulgent Genetics offers a variety of tests in this area and has already achieved great success. Overall, Fulgent Genetics offers a wide range of products and services mainly focused on the diagnosis of genetic diseases. However, the company also goes beyond that and provides solutions for a wide range of customers and applications. Fulgent Genetics is based in the US and has experienced rapid growth since its founding. The company's success is also reflected in the many awards it has received. It has been recognized multiple times and has established a reputation as one of the leading biotechnology companies in the world. Fulgent Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Fulgent Genetics's Equity

Fulgent Genetics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Fulgent Genetics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Fulgent Genetics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Fulgent Genetics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Fulgent Genetics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Fulgent Genetics stock

What is the equity of Fulgent Genetics this year?

Fulgent Genetics has equity of 1.14 B USD this year.

What was the equity of Fulgent Genetics compared to the previous year?

The equity of Fulgent Genetics has increased/decreased by -10.31% decreased compared to the previous year.

What impact does a high equity have on investors of Fulgent Genetics?

A high equity is advantageous for investors of Fulgent Genetics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Fulgent Genetics?

A low equity can be a risk for investors of Fulgent Genetics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Fulgent Genetics affect the company?

An increase in equity of Fulgent Genetics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Fulgent Genetics affect the company?

A reduction in equity of Fulgent Genetics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Fulgent Genetics?

Some factors that can affect the equity of Fulgent Genetics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Fulgent Genetics so important for investors?

The equity of Fulgent Genetics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Fulgent Genetics take to change the equity?

To change equity, Fulgent Genetics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Fulgent Genetics pay?

Over the past 12 months, Fulgent Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fulgent Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Fulgent Genetics?

The current dividend yield of Fulgent Genetics is .

When does Fulgent Genetics pay dividends?

Fulgent Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fulgent Genetics?

Fulgent Genetics paid dividends every year for the past 0 years.

What is the dividend of Fulgent Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fulgent Genetics located?

Fulgent Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fulgent Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fulgent Genetics from 11/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Fulgent Genetics pay the last dividend?

The last dividend was paid out on 11/15/2024.

What was the dividend of Fulgent Genetics in the year 2023?

In the year 2023, Fulgent Genetics distributed 0 USD as dividends.

In which currency does Fulgent Genetics pay out the dividend?

The dividends of Fulgent Genetics are distributed in USD.